October 30, 2008  September, 2009 Glen Clack December, 2008 David Kerr
 |
Tim HUNT
2001 Nobel Prize in Physiology or Medicine
London Research Institute, London
INAUGURAL LECTURE
Tim Hunt's laboratory studies the structure, function and destruction of CDKs, which control cell cycle transitions. With a particular interest in the role of cyclins in the activation of CDK1 and CDK2, they try to understand how particular cyclins control particular processes.
Description of the event
|
| December 08, 2008 October, 2008 Tim HuntJanuary, 2009 Carlos Caldas
 |
David KERR
University of Oxford, Oxford
CLINICAL VISION
The translational research challenges in cancerology
David Kerr's team has an international reputation for the treatment of and research into colorectal cancer, and is developing new approaches to cancer treatment which involve novel inhibitors of key biochemical pathways
Description of the event
|
| January 26, 2009 December, 2008 David KerrFebruary, 2009 Claude BOCCARA
 |
Carlos Caldas
University of Cambridge, Cambridge
16h30, Salle DUSSANE, ENS, 45 rue d'Ulm
CLINICAL VISION
Carlos Caldas' laboratory is interested in understanding how genetic alterations accumulate and how they determine the biological behaviour of cancers. Ultimately they aim to identify patterns that are predictive of outcome and can be used to guide therapy.
Carlos Caldas is one of the most reknown experts in microarrays.
|
| February, 2009 January, 2009 Carlos CaldasMarch, 2009 Anton Berns
 |
Claude BOCCARA
ESPCI
IMAGING STATE OF ART
To be defined
|
| March 04, 2009 February, 2009 Claude BOCCARAApril, 2009 Anne-lise Borresenn-Dale
 |
Anton BERNS
Netherlands Cancer Institute, Amsterdam
14h30, Salle DUSSANE, ENS, 45 rue d'Ulm
IMAGING STATE OF ART
Human-animal correlation
Anton Bern's group has done pioneering work to generate and utilize genetically modified mice as a tool to search for new cancer genes. Their focus is on the development and use of advanced mouse models for cancer that closely mimic the human condition
Description of the event
|
| April 29, 2009 March, 2009 Anton BernsMay, 2009 Gilles Thomas
 |
Anne-Lise BØRRESEN-DALE
Norwegian Radium Hospital, Oslo
17h00, Amphi du Pôle de Biologie du Développement, Institut Curie - 11, rue Pierre et Marie Curie
MOLECULAR BIOLOGY AND BIOINFORMATIC
Pharmacogenomic and Breast Cancer
Description of the event
|
| May 07, 2009 April, 2009 Anne-lise Borresenn-DaleJune, 2009 Amir Gandjbakhche
 |
2009, May 7
Gilles THOMAS
National Cancer Institute, Bethesda
11h00, Amphithéâtre Paul LANGEVIN, ESPCI - 10, rue Vauquelin
MOLECULAR BIOLOGY AND BIOINFORMATIC
Wide screen profiling and individual disease
Description of the event
|
| June 10, 2009 May, 2009 Gilles ThomasJuly, 2009 Alan Barge
Amir Gandjbakhche
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) - Rockville, MD - USA
17h00 - Amphithéâtre du Pôle de Biologie du Développement - Institut Curie - 11, rue Pierre et Marie Curie -75005 Paris
In 1989, Amir Gandjbakhche got a doctorate in Biomedical Engineering from the Physics Department of the University Denis Diderot. Since 1990 he works at NIH on Diagnostic Photonics Technology and Methodology from Bench to Bedside. He is currently: Senior Investigator - Chief Section on Analytical and Functional Biophotonics Physical Biology Program at the Eunice Shriver National Institute of Child Health and Human Development - National Institutes of Health Description of the event | July, 2009 June, 2009 Amir GandjbakhcheSeptember, 2009 Glen Clack
 |
Alan Barge
AstraZeneca, Macclesfield – June 2009
17h00, Amphi du Pôle de Biologie du Développement, Institut Curie - 11, rue Pierre et Marie Curie
Drug Discovery Challenge within the Translational Vision
Alan Barge trained in medicine and oncology in the UK, and the US. His current responsibilities include the development of AstraZeneca's early phase compounds in the areas of angiogenesis inhibition, vascular targeting and anti-invasion.
Description of the event
|
| September 17, 2009 July, 2009 Alan BargeOctober, 2008 Tim Hunt
 |
Glen CLACK
AstraZeneca Pharmaceuticals - Macclesfield Cheshire
17h00, Amphi du Pôle de Biologie du Développement, Institut Curie - 11, rue Pierre et Marie Curie
Translational Science, Myths and Realities
Description of the event
|
|
